Arkray‘s U.S. subsidiary launched today its Adams A1c HA-8180V system for hemoglobin A1c testing. The device is indicated to help diagnose and monitor people with diabetes, the Edina, Minn.-based company reported. Get the full story at our sister site, Drug Delivery Business News.
Abbott nabs U.K. reimbursement win for FreeStyle Libre CGM
Abbott (NYSE:ABT) said today that its FreeStyle Libre continuous glucose monitoring system will be available for reimbursement in the U.K., starting on Nov. 1. The company’s system is designed to automatically read glucose levels through a sensor that’s worn on the back of a person’s upper arm for up to 14 days, thereby eliminating routine finger […]
Senseonics wins CE Mark for Eversense XL glucose monitor
Senseonics (NYSE:SENS) said yesterday that it won CE Mark approval in the European Union for its Eversense XL continuous glucose monitor. The Eversense XL includes a glucose sensor designed to be implanted for 180 days and a removable smart transmitter that links with a mobile app for real-time glucose monitoring. Germantown, Md.-based Senseonics touts the sensor […]
This smart mat can predict the onset of foot ulcers
A Massachusetts Institute of Technology hackathon participant developed a smart mat that helps detect early warning signs of foot ulcers. Jon Bloom, co-founder of startup company Podimetrics, developed a mat that can detect foot ulcers before they happen and reduce the number of amputations occurring. Bloom completed his residency in anesthesiology at Massachusetts General Hospital in […]
Fractyl Labs touts 1-year data for Revita DMR in T2D patients
Fractyl Laboratories touted data today showing sustained improvement in glycemic parameters after one year following a single treatment with its Revita duodenal mucosal resurfacing system in patients with Type II diabetes. “This is the first presentation of one-year data on the durability of the Revita DMR procedure in Type II diabetes. The Revita DMR procedure was […]
Medtronic recalls insulin infusion sets
Medtronic (NYSE:MDT) said today that it’s recalling some of the infusion sets used with its insulin pumps due to problems with a discontinued component. The Fridley, Minn.-based medical device titan said the problem involves a vent membrane that’s susceptible to blockage during priming and fill-tubing. No pumps or glucose sensors are affected by the recall, Medtronic […]
Tandem Diabetes Care shareholders approve reverse split
Tandem Diabetes Care (NSDQ:TNDM) shareholders met yesterday and approved a proposal to effect a reverse stock split at a ratio between 1-for-8 and 1-for-12, according to a regulatory document. In a statement filed with the SEC in July, the San Diego, Calif.-based company told shareholders that it believed a reverse stock split would help Tandem keep […]
Nordisk settles DOJ’s Victoza marketing suit for $59m
Novo Nordisk (NYSE:NVO) said yesterday afternoon that it inked a $58.7 million deal with the U.S. Dept. of Justice to settle an investigation into the company’s marketing practices for Victoza – its Type II diabetes drug. The agreement settles eight different lawsuits alleging that the drugmaker misled doctors by dressing salespeople as medical educators, paying physicians […]
Sanofi wins tentative FDA nod for Admelog insulin lispro injection
Sanofi (NYSE:SNY) said today that the FDA granted the company tentative approval for its Admelog insulin lispro injection. The decision is based on physicochemical, non-clinical and clinical similarity to another, already-approved insulin lispro injection. The compound is contraindicated during hypoglycemia episodes and in patients with hypersensitivity to insulin lispro or one of its other ingredients, Sanofi […]
Diabetes orgs send insulin, glucose meters to Texas
Thousands of people in Texas have been displaced from their homes after Hurricane Harvey landed there last week, leaving many without life-saving medication and supplies. People with diabetes are especially vulnerable, since many require daily insulin injections and regular monitoring of their blood glucose levels. In what they have described as a ‘landmark partnership’, the […]
Abbott’s FreeStyle Libre wins reimbursement in Japan
Abbott (NYSE:ABT) said today that the Ministry of Health Labor and Welfare in Japan has granted national reimbursement for the company’s FreeStyle Libre glucose monitoring system. The FreeStyle Libre system uses a small sensor worn on the back of the upper arm to measure glucose every minute in interstitial fluid through a filament inserted under the […]
- 1
- 2
- 3
- …
- 44
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+